The 14th European AIDS Conference, organised by the European AIDS Clinical Society (EACS), took place in Brussels, Belgium, 16-19 October 2013. NAM was the official provider of online science news.

Conference highlights

Keynote speech on need for action in eastern Europe

Eastern Europe facing quadruple epidemic while governments do nothing, warns UN Special Envoy.

Conference bulletins

All our conference bulletins, available in English, French, Spanish, Portuguese, Italian and Russian.

Conference opens with strong political statements

European physicians condemn impact of Russian anti-gay law on HIV prevention and care.


New EACS guidelines

A new edition of the European AIDS Clinical Society (EACS) guidelines for the treatment of HIV were published in advance of the conference.

Microbicides symposium

Researchers and advocates met at a satellite symposium to discuss the microbicides pipeline in Europe.

Conference website

Visit the official conference website.


Future HIV treatment

The closing lecture on Saturday offered an overview of the future of HIV drug development.

New HIV drug: cenicriviroc

Results of a phase two trial, comparing the CCR5/CCR2 inhibitor cenicriviroc with efavirenz.

HIV care in Europe

Ensuring good-quality HIV care in Europe: where can we improve?


aidsmap news

There is no aidsmap news from EACS 2013 yet. Showing all aidsmap news instead.

Editors' picks from other sources

There are no Editors' Picks from EACS 2013 yet. Showing all Editors' picks instead.

News bulletins

Sign up for our email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more about the conference on the official conference website.

Visit the conference website >

aidsmap news apps

Keep up to date with the latest HIV news using the free aidsmap news iPhone and android apps.

Download the app >

NAM's coverage of the 14th European AIDS Conference has been made possible thanks to support from the European AIDS Clinical Society (EACS) and Merck & Co., Inc.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.